Intuitive Surgical (ISRG) was lower in the session, extending a pullback that has been driven less by fresh operational headlines and more by investors recalibrating expectations for 2026 growth and what they are willing to pay for it. The key debate has been whether da Vinci procedure growth can remain strong enough to justify the stock’s elevated multiple after management’s 2026 procedure-growth outlook was viewed as a deceleration versus prior years.

After the company’s most recent outlook commentary, attention has centered on expectations for worldwide da Vinci procedure growth in 2026 in the mid-teens, a step down that increases sensitivity to any sign of demand normalization, hospital budget pressure, or mix shifts that could pressure margins. With ISRG valued as a long-duration compounder, even modest trims to growth assumptions can translate into sharper near-term multiple compression on down-market days.

Risk appetite around the name has also been affected by the company’s March 2026 disclosure of a cybersecurity incident involving unauthorized access to certain internal IT business applications. While the disclosure emphasized containment and investigation, and did not characterize an impact to core surgical platforms in the initial reports, the headline has added another layer of uncertainty for investors already focused on valuation and forward growth assumptions.